Dermatomyositis enters ‘new therapeutic era’

CLEVELAND — Researchers are beginning to understand the pathogenesis of dermatomyositis, leading to new, targeted therapies for the disease, according to a speaker at Cleveland Clinic’s Medical Dermatology Therapy Update IV. “Dermatomyositis is starting to have its moment,” Lisa Christopher-Stine, MD, MPH, director of Johns Hopkins Myositis Precision Medicine Center of Excellence, told

Raccontata dahealio.com